Hospital Management

Hospital Management

Publication
0 followers

Global hospital management, operations, and procurement industry news.

Lyell Doses First Patient in Phase III Trial for LBCL
NewsFeb 13, 2026

Lyell Doses First Patient in Phase III Trial for LBCL

Lyell Immunopharma has administered the first dose of its investigational CAR‑T therapy, ronde‑cel (LYL314), in the Phase III PiNACLE‑H2H trial for relapsed or refractory large B‑cell lymphoma. The head‑to‑head study randomizes roughly 400 patients to receive either ronde‑cel at 100 × 10⁶ cells...

By Hospital Management
BioRestorative Concludes Phase II BRTX-100 Trial Enrolment for cLDD
NewsFeb 11, 2026

BioRestorative Concludes Phase II BRTX-100 Trial Enrolment for cLDD

BioRestorative Therapies announced completion of patient enrollment for its Phase II BRTX‑100 trial in chronic lumbar disc disease, enrolling 99 subjects at 15 U.S. sites. The double‑blind, sham‑controlled study randomizes participants 2:1 to receive an autologous hypoxically cultured mesenchymal stem cell...

By Hospital Management